Trends - BioNTech - Business Recorder

BioNTech

Record US virus cases as reports say British queen to get vaccine soon

Cafes will continue to serve only takeaways, while restaurants must close by 9 pm, with only deliveries permitted afterwards.

Updated 06 Dec, 2020 06:22pm

World

Norway to use three vaccines to stop COVID-19 from early 2021

In the first quarter of 2021, Oslo expects to receive a total of 2.5 million doses, covering 1.25 million people, pending approval of the vaccines from European regulators. Norway's population is 5.4 million.

Published 04 Dec, 2020 06:00pm

Business & Finance

UK approves Pfizer-BioNTech COVID-19 vaccine in world first

UK first in the world to approve Pfizer-BioNTech vaccine.
Vaccine roll out from early next week.
'Fantastic news', says PM Johnson.
Medicine regulator approves vaccine in record time.
EU watchdog urges longer approval process.

Published 03 Dec, 2020 12:15am

World

EU warns of risks of COVID-19 vaccine race after UK approval of Pfizer shot

Britain is the first Western country to approve a COVID-19 vaccine, a move that many see as a political coup for Prime Minister Boris Johnson's government.

Published 02 Dec, 2020 03:23pm

World

EU Commission to authorise COVID vaccines days after regulatory approval

Under EU rules, EMA recommends the authorisation of a drug or vaccine and the EU Commission authorizes them on the basis of the EMA's scientific advice.

Published 01 Dec, 2020 05:01pm

Business & Finance

BioNTech/Pfizer file for EU approval of Covid-19 vaccine

The two vaccines have been developed at breathtaking speed as part of an unprecedented effort to end a pandemic that has infected more than 62 million people worldwide and killed more than 1.4 million.

Published 01 Dec, 2020 04:16pm

World

Ten COVID-19 vaccines seen by mid-year, head of global pharma group says

Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials.

Published 28 Nov, 2020 10:35am

Business & Finance

Pfizer to submit U.S. emergency use application for COVID-19 vaccine

Pfizer said nearly 42pc of global participants and 30pc of U.S. participants in the Phase 3 study have racially and ethnically diverse backgrounds.

Published 20 Nov, 2020 07:09pm

Business & Finance

Israel signs deal with Pfizer for potential COVID-19 vaccine

Pfizer and German partner BioNTech SE confirmed a deal was forthcoming in a statement on Thursday but did not disclose financial details.
In televised remarks, Netanyahu said the agreement marked "a great day for Israel" and added: "The goal is for the vaccine supply to start in January and increase in the months thereafter".

Published 13 Nov, 2020 05:37pm

World

New Pfizer, BioNTech coronavirus vaccine may not be suitable for Asian countries

Some Asian countries are prioritising containing the novel coronavirus rather than looking to stockpile vaccines, while others are looking for alternatives to the messenger RNA technology used by Pfizer that requires such ultra-cold storage.

Published 10 Nov, 2020 05:27pm

Business & Finance

BioNTech to price vaccine below market rates, differentiate between regions

BioNTech strategy head says price will reflect investors' risk Says production ramp-up will continue throughout 2021.
Volumes will be significant in H1, but scaling up also in H2.
CEPI head: BioNTech, Pfizer received no "substantial" subsidies.

Published 10 Nov, 2020 05:15pm

Business & Finance

BioNTech hopes COVID-19 vaccine will immunize for at least a year

Says high antibody levels tend not to peter out fast.
Says for now vaccine can last 5 days in fridge.
For longer storage, needs -70 degrees C.
December data may allow for longer fridge storage.

Published 09 Nov, 2020 07:32pm

Business & Finance

Pfizer and BioNTech say their COVID-19 vaccine is over 90pc effective

Pfizer and German partner BioNTech SE are the first drugmakers to release successful data from a large-scale clinical trial of a coronavirus vaccine.
We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records,

Published 09 Nov, 2020 05:25pm

Business & Finance

New Zealand signs deal with Pfizer, BioNTech for COVID-19 vaccine

The government did not disclose financial terms of the deal, its first vaccine purchase, which will provide enough doses to vaccinate 750,000 people.

Published 12 Oct, 2020 10:09am

World

EU reviewing Pfizer-BioNTech COVID-19 vaccine in real time

Pfizer's vaccine is currently being evaluated in late-stage studies in the United States, Brazil, South Africa and Argentina.

Published 06 Oct, 2020 03:28pm

Business & Finance

Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial

"BioNTech's vaccine candidate is not part of this study," a spokeswoman said.
AstraZeneca and Sanofi and Moderna , among the leading vaccine developers, have said their vaccine candidates were not involved in the programme.

Published 24 Sep, 2020 11:49pm

Business & Finance

BioNTech buys German site from Novartis to boost vaccine output

To boost 2021 output of doses by several hundred millions.
BioNTech CEO: Request for approval likely late-Oct, early-Nov.
Expects storage at fridge temperature over 2 weeks or longer.
Says eyeing vaccine efficacy of 70-75%.

Published 17 Sep, 2020 05:51pm

Business & Finance

Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteers

The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
The proposed expansion would allow the companies to enroll people as young as 16 and people with chronic, stable HIV, hepatitis C and hepatitis B.

Published 12 Sep, 2020 09:05pm

World

German-Chinese coronavirus vaccine trial begins in China

The vaccine candidate, known as BNT162b1, is one of four based on BioNTech's proprietary mRNA technology.

Published 05 Aug, 2020 05:46pm

Business & Finance

Pfizer, BioNTech to supply 120mn doses of coronavirus vaccine to Japan

The companies did not disclose the financial details of the agreement, but said terms were based on the volume of doses and the timing of the delivery.

Published 31 Jul, 2020 04:16pm

Business & Finance

US to pay Pfizer, BioNTech $1.95bn for 100mn COVID-19 vaccine doses

Pfizer and BioNTech will not receive any money from the government unless their vaccine succeeds in large clinical trials and can be successfully manufactured.
The Pfizer/BioNTech candidate is one of the most advanced of over 150 vaccines being developed against COVID-19.

Published 22 Jul, 2020 11:18pm

US signs $2 billion vaccine deal with Pfizer and BioNTech

It is the biggest deal to date under Operation Warp Speed, intended to accelerate the development, manufacturing, and distribution of coronavirus vaccines, therapeutics, and diagnostics.

Published 22 Jul, 2020 08:51pm

World

UK secures 90 million doses of potential cornavirus vaccines

"The hunt to find a vaccine is a truly global endeavour and we are doing everything we can to ensure the British public get access to a safe and effective coronavirus vaccine as soon as possible," said Sharma.

Published 20 Jul, 2020 06:23pm

Business & Finance

Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status

The candidates, BNT162b1 and BNT162b2, are the most advanced of the at least four vaccines being assessed by the companies in ongoing trials in the United States and Germany.
Early data from the German trial of BNT162b1 are expected to be released in July, the companies said.

Published 13 Jul, 2020 06:47pm

Business & Finance

Temasek-led investor group in $250mn vaccine bet on Germany's BioNTech

The investment, which BioNTech said was via a private placement, reflects heightened investor interest in the race to develop an agent.
It has said it expects first clinical data on its COVID-19 vaccine development programme known as BNT162 this month or in July.

Published 29 Jun, 2020 07:22pm

Gainers
Losers
Leaders

Stock	Price
786 Invest Ltd / Jul 2 786 Investments Limited(786)	5.00 ▼ 0.00 (0.00%)
AL-Abbas Sugar / Jul 2 Al-Abbas Sugar Mills Limited(AABS)	272.50 ▼ 0.00 (0.00%)
Agro Allianz / Jul 2 Agro Allianz Limited(AAL)	16.00 ▼ 0.00 (0.00%)
AL-Abid Silk / Jul 2 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / Jul 2 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / Jul 2 Allied Bank Limited(ABL)	69.05 ▼ 0.00 (0.00%)
Abbott Lab. / Jul 2 Abbott Laboratories (Pakistan) Limited(ABOT)	666.00 ▼ 0.00 (0.00%)
Abson Ind. / Jul 2 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Alfalah ETF. / Jul 2 Alfalah Consumer Index ETF.(ACIETF)	7.84 ▼ 0.00 (0.00%)
Attock Cement / Jul 2 Attock Cement Pakistan Limited(ACPL)	67.13 ▼ 0.00 (0.00%)

Stock	Price
786 Invest Ltd / Jul 2 786 Investments Limited(786)	5.00 ▼ 0.00 (0.00%)
AL-Abbas Sugar / Jul 2 Al-Abbas Sugar Mills Limited(AABS)	272.50 ▼ 0.00 (0.00%)
Agro Allianz / Jul 2 Agro Allianz Limited(AAL)	16.00 ▼ 0.00 (0.00%)
AL-Abid Silk / Jul 2 Al-Abid Silk Mills Limited(AASM)	3.49 ▼ 0.00 (0.00%)
Ali Asghar / Jul 2 Ali Asghar Textile Mills Limited(AATM)	2.07 ▼ 0.00 (0.00%)
Allied Bank / Jul 2 Allied Bank Limited(ABL)	69.05 ▼ 0.00 (0.00%)
Abbott Lab. / Jul 2 Abbott Laboratories (Pakistan) Limited(ABOT)	666.00 ▼ 0.00 (0.00%)
Abson Ind. / Jul 2 Abson Industries Limited(ABSON)	2.50 ▼ 0.00 (0.00%)
Alfalah ETF. / Jul 2 Alfalah Consumer Index ETF.(ACIETF)	7.84 ▼ 0.00 (0.00%)
Attock Cement / Jul 2 Attock Cement Pakistan Limited(ACPL)	67.13 ▼ 0.00 (0.00%)

Stock	Volume

Markets →

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / Jun 30	204.90
USD PKR Interbank Buying / Jun 30	204.70
USD to Japanese Yen / Jul 1	135.21
USD to Swiss Franc / Jul 1	0.96
Pound Sterling to USD / Jul 1	1.21
Euro to USD / Jul 1	1.04
UK LIBOR % / Jul 1	1.58

Stock	Volume
S&P 500 / Jul 1	3825.33
India Sensex / Jul 1	52907.93
Tokyo Nikkei / Jul 1	26935.62
Nasdaq / Jul 1	11127.84
Hang Seng / Jul 1	21859.79
FTSE 100 / Jul 1	7168.65
Dow Jones / Jul 1	31097.26
Germany DAX 30 / Jul 1	12813.03
France CAC40 / Jul 1	5931.06

Item	Value
Crude Oil USD/Barrel / Jul 1	108.43
Karachi Cotton PKR/37.32 KG / Jul 1	17380.00
Gold 10 Grams PKR / Jul 1	119100.00
Gold Spot USD/Ounce / Jul 1	1811.43
Cotton US¢/pound / Jul 1	97.48

BioNTech

Most Popular Articles